API australian pharmaceutical industries limited

News: API books turnaround H1 profit

  1. lightbulb Created with Sketch. 1
    .


    Shares in Australian Pharmaceutical Industries Limited (ASX:API) rose yesterday after the pharmaceutical distributor and retailer revealed it had swung from a loss to a first half profit.



    The company that owns Priceline stores beat market expectations with first half net profit of $18.3 million, with underlying net profit growing 10 per cent to $11.8 million.



    Chief Stephen Roche has described the result as solid and flagged significant growth between now and 2015.



    A fully-franked interim dividend of 1.5 cents per share has been declared and the company has forecast earnings growth in the second half, assuming no change in conditions. 



    Shares in Australian Pharmaceutical Industries gained 8.82 per cent on Thursday, closing at $0.37.


 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.